| Absci is a generative artificial intelligence (AI) drug creation company utilizing deep learning and synthetic biology for therapeutic potential of proteins. Co. utilizes its integrated drug creation platform to identify drug targets and create biotherapeutic candidates. Co.'s Integrated Drug Creation platform combines: the data to train, in which its SoluPro technology constructs genetically-distinct cells; the AI to Create, which designs new therapeutic candidates using generative AI models; and the wet lab to validate, which supports its generative AI designs with its wet lab's throughput functional validation capabilities. We show 10 historical shares outstanding datapoints in our coverage of ABSI's shares outstanding history.
Understanding the changing numbers of ABSI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABSI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABSI by allowing them to research ABSI shares outstanding history
as well as any other stock in our coverage universe.